NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Revalesio

Revalesio

Private
Tacoma, WashingtonHealthcare & Life Scienceshttps://revalesio.com/

Last Round

VC Round

Jun 9, 2022

Total Funding Raised

$14.5M

Company Overview

Revalesio is a biotechnology company that develops anti-inflammatory therapeutic drugs designed to treat a variety of neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

neurological therapeuticsRNS60acute ischemic strokeALS treatmentmitochondrial dysfunctionclinical stage pharmaneuroprotectionneurodegenerative diseasecytoprotective agentpharma licensingphysics-based formulationorphan drugfast track designationinflammatory modulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Revalesio Comparables

Compare Revalesio with similar companies based on industry and business-model similarity.

Revalesio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZZ Biotech
84%
Astrocyte Pharmaceuticals Inc.
82%
Pharmazz, Inc.
79%

Revalesio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 9, 2022
VC RoundJul 22, 2020
VC RoundJun 27, 2018
GrantSep 20, 2017
VC RoundJul 5, 2016
Series B
Apr 23, 2014

Revalesio Investors

Notable investors and investment history

Revalesio investors
InvestorRounds
The ALS AssociationGrant
Northeast ALS ConsortiumGrant
ALS Finding a CureGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors increased 1706% MoM to 1.3K.

  • Jun 9, 2022

    Raised $13M in a venture round.

Revalesio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Revalesio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Revalesio's valuation, stock price, and market status.

Firmographic Details

HeadquartersTacoma, Washington
Employee Range21
Year Founded2000
Last FundingJun 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.